Printed proof derived from clinical trials analyzing the efficacy and security of CBD in patients with gastrointestinal Conditions remains scarce. That fact led Dr. Camilleri and Mayo Clinic colleagues to conduct a randomized managed trial investigating using CBD in clients with gastroparesis.